Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

101.23
BATS BZX Real-Time Price
As of 12:06pm ET
 +0.50 / +0.50%
Today’s Change
92.56
Today|||52-Week Range
141.86
+3.97%
Year-to-Date
BridgeBio Calls Off Its Acquisition Offer for Eidos Therapeutics
Oct 19 / MotleyFool.com - Paid Partner Content
Will The Pace of M&A Pick Up Following The Biotech Sector’s Pounding?
Oct 11 / MotleyFool.com - Paid Partner Content
Why Achillion Pharmaceuticals, Tech Data, and First Majestic Silver Jumped Today
Oct 16 / MotleyFool.com - Paid Partner Content
Here's Why Stealth BioTherapeutics Rocketed Higher Today
Oct 10 / MotleyFool.com - Paid Partner Content
Why Achillion Pharmaceuticals Stock Is Skyrocketing Today
Oct 16 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close100.73
Today’s open101.96
Day’s range100.19 - 103.36
Volume520,558
Average volume (3 months)2,176,450
Market cap$22.1B
Data as of 12:06pm ET, 10/22/2019

Growth & Valuation

Earnings growth (last year)-82.40%
Earnings growth (this year)+25.73%
Earnings growth (next 5 years)+12.45%
Revenue growth (last year)+17.00%
P/E ratio17.1
Price/Sales5.29
Price/Book2.40

Competitors

 Today’s
change
Today’s
% change
SGENSeattle Genetics Inc-2.43-2.41%
INCYIncyte Corp+0.61+0.78%
REGNRegeneron Pharmaceut...+6.27+2.10%
ALNYAlnylam Pharmaceutic...+1.63+1.88%
Data as of 12:06pm ET, 10/22/2019

Financials

Next reporting dateOctober 23, 2019
EPS forecast (this quarter)$2.48
Annual revenue (last year)$4.1B
Annual profit (last year)$77.6M
Net profit margin1.88%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Boston, Massachusetts

Forecasts